We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Phigenix Fights $2.2M Atty Fee Bid In Cancer Drug IP Row

Law360 (November 27, 2018, 7:58 PM EST) -- Phigenix Inc. is fighting Genentech Inc.’s request for more than $2.2 million in attorneys’ fees after beating a patent infringement suit in California federal court over the breast cancer drug Kadcyla....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

California Northern

Nature of Suit

Patent

Judge

Subscribers Only

Date Filed

March 17, 2015

Law Firms

Companies

Government Agencies

Patents

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.